? LEADERSHIP, PLANNING AND EVALUATION Under the new UWCCC Director Howard Bailey, MD, a number of critical steps were taken in the planning and evaluation process during the current grant period include the following: assembled a revised EAB to evaluate the UWCCC; increased scientific forums for collaborative efforts in response to strategic priorities; obtained expert evaluations for strategic planning; and conducted off-site peer visits. Change of leadership in any organization provides an opportunity for assessment and redirection. In 2015, new UWCCC leadership priorities embraced an assessment of all internal operations, surveillance of the Oncology research environment, and the eventual application of analysis-driven redirection. This occurred through regular and strategic planning meetings of individual focus groups/committees of the Cancer Service Line; Executive Leadership Council; Senior Leadership Committee; Director?s Committee; Membership Committee; Ad-Hoc External Scientific Advisors; External Advisory Board; and annual scientific retreats. UWCCC added new leadership with the appointments of new Associate Director(s) in Faculty Development and Education, Clinical Research, Administration, Basic Sciences, Translational Research, and Shared Resources. Existing leadership from the prior renewal include Associate Directors in Population Sciences and in Informatics. All UWCCC leadership roles further the center?s mission by serving faculty members, serving employees, serving our patients, and serving our catchment area. We work collectively to guide planning and evaluations, create a vision, set goals, assess progress, and set the agenda for future directions. Senior Leadership determines strategies to leverage the breadth and depth of science on the UW-Madison campus. Meeting at least monthly, they carefully identify and foster research capabilities that will strengthen the UWCCC?s Scientific Programs and extend cancer focus into new areas.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Center Core Grants (P30)
Project #
Application #
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Wisconsin Madison
United States
Zip Code
Carroll, Molly J; Fogg, Kaitlin C; Patel, Harin A et al. (2018) Alternatively-Activated Macrophages Upregulate Mesothelial Expression of P-Selectin to Enhance Adhesion of Ovarian Cancer Cells. Cancer Res 78:3560-3573
Ehlerding, Emily B; Grodzinski, Piotr; Cai, Weibo et al. (2018) Big Potential from Small Agents: Nanoparticles for Imaging-Based Companion Diagnostics. ACS Nano 12:2106-2121
Liu, Bai; Jones, Monica; Kong, Lin et al. (2018) Evaluation of the biological activities of the IL-15 superagonist complex, ALT-803, following intravenous versus subcutaneous administration in murine models. Cytokine 107:105-112
Yu, Deyang; Yang, Shany E; Miller, Blake R et al. (2018) Short-term methionine deprivation improves metabolic health via sexually dimorphic, mTORC1-independent mechanisms. FASEB J 32:3471-3482
Morris, Zachary S; Guy, Emily I; Werner, Lauryn R et al. (2018) Tumor-Specific Inhibition of In Situ Vaccination by Distant Untreated Tumor Sites. Cancer Immunol Res 6:825-834
Yu, Bo; Goel, Shreya; Ni, Dalong et al. (2018) Reassembly of 89 Zr-Labeled Cancer Cell Membranes into Multicompartment Membrane-Derived Liposomes for PET-Trackable Tumor-Targeted Theranostics. Adv Mater 30:e1704934
Park, Linda; Schwei, R J; Xiong, P et al. (2018) Addressing Cultural Determinants of Health for Latino and Hmong Patients with Limited English Proficiency: Practical Strategies to Reduce Health Disparities. J Racial Ethn Health Disparities 5:536-544
Ehlerding, Emily B; Lan, Xiaoli; Cai, Weibo (2018) ""Albumin Hitchhiking"" with an Evans Blue Analog for Cancer Theranostics. Theranostics 8:812-814
Jadvar, Hossein; Chen, Xiaoyuan; Cai, Weibo et al. (2018) Radiotheranostics in Cancer Diagnosis and Management. Radiology 286:388-400
Denu, Ryan A; Shabbir, Maria; Nihal, Minakshi et al. (2018) Centriole Overduplication is the Predominant Mechanism Leading to Centrosome Amplification in Melanoma. Mol Cancer Res 16:517-527

Showing the most recent 10 out of 1528 publications